AVNphotolab / iStockphoto.com
31 May 2017Big Pharma
English High Court rejects UCB’s request for summary judgment
The English High Court has dismissed UCB Pharma’s request for summary judgment in a case against Chugai Pharmaceutical.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
28 August 2018 Late last week, Chugai Pharmaceutical emerged victorious after the English High Court found that the Japan-based company doesn’t owe royalties under a patent licence with UCB.
Editor's picks
Editor's picks
Big Pharma
28 August 2018 Late last week, Chugai Pharmaceutical emerged victorious after the English High Court found that the Japan-based company doesn’t owe royalties under a patent licence with UCB.
Big Pharma
28 August 2018 Late last week, Chugai Pharmaceutical emerged victorious after the English High Court found that the Japan-based company doesn’t owe royalties under a patent licence with UCB.